224 related articles for article (PubMed ID: 11007041)
1. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
3. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209
[TBL] [Abstract][Full Text] [Related]
4. [Intracellular distribution of beta-catenin in soft tissue tumors].
Kuhnen C; Herter P; Steinau HU; Müller O; Müller KM
Verh Dtsch Ges Pathol; 1998; 82():322-6. PubMed ID: 10095453
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
[TBL] [Abstract][Full Text] [Related]
6. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma.
Hasegawa T; Yokoyama R; Matsuno Y; Shimoda T; Hirohashi S
Hum Pathol; 2001 Mar; 32(3):257-63. PubMed ID: 11274633
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
10. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
11. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
Engellau J; Bendahl PO; Persson A; Domanski HA; Akerman M; Gustafson P; Alvegård TA; Nilbert M; Rydholm A
Hum Pathol; 2005 Sep; 36(9):994-1002. PubMed ID: 16153463
[TBL] [Abstract][Full Text] [Related]
12. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
14. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
Saegusa M; Hashimura M; Yoshida T; Okayasu I
Br J Cancer; 2001 Jan; 84(2):209-17. PubMed ID: 11161379
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
[TBL] [Abstract][Full Text] [Related]
16. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
18. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas.
Hrzenjak A; Tippl M; Kremser ML; Strohmeier B; Guelly C; Neumeister D; Lax S; Moinfar F; Tabrizi AD; Isadi-Moud N; Zatloukal K; Denk H
J Pathol; 2004 Sep; 204(1):19-27. PubMed ID: 15307134
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
20. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
